Obesity

>

Latest News

FDA accepts setmelanotide NDA for obesity in patients down to 2 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts setmelanotide NDA for obesity in patients down to 2 years

August 26th 2024

Following the FDA's acceptance of the NDA, a PDUFA date of December 26, 2024 has been set for setmelanotide in patients as young as 2 years of age.

 Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: Digital technologies for mental health, obesity, and more

August 12th 2024

Text messaging programs and childhood obesity | Image Credit: © majivecka - © majivecka - stock.adobe.com.
Digital health programs and childhood obesity

August 8th 2024

Maternal obesity linked to increased risk of sudden unexpected infant death | Image Credit: © alekseyvanin - © alekseyvanin - stock.adobe.com.
Maternal obesity linked to increased risk of sudden unexpected infant death

July 30th 2024

Obesity in the adolescent and young adult populations | Image Credit: © alekseyvanin - © alekseyvanin - stock.adobe.com.
Obesity in the adolescent and young adult populations

July 23rd 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.